In December 2019, a novel coronavirus, termed severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), was identified as the cause of pneumonia with severe …

© 2022. Bratislava Medical Journal. All Rights Reserved. BACKGROUND: A pyrimidine
based Schiff base was examined in this report. Structural and spectral characterizations …

The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic
warrants an imperative necessity for effective and safe vaccination, to restrain Coronavirus …

The COVID-19 pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2) heavily burdened the entire world. Despite a prompt generation of vaccines …

The emergence and rapid spread of novel variants of concern (VOC) of the coronavirus 2
constitute a major challenge for spatial disease surveillance. We explore the possibility to …

Since the beginning of 2020, the COVID-19 pandemic has posed unprecedented
challenges to viral data analysis and connected host disease diagnostic methods. We …

Whereas randomized clinical trials remain the gold standard for evaluating new therapies for
infections, we argue that registries and observational studies early in the coronavirus …

Ending COVID-19 pandemic requires a collaborative understanding of SARS-CoV-2 and
COVID-19 mechanisms. Yet, the evolving nature of coronaviruses results in a continuous …

SARS-CoV-2 has significantly mutated its genome during the past 3 years, leading to the
periodic emergence of several variants. Some of the variants possess enhanced fitness …

With the global epidemic of SARS-CoV-2, it is important to effectively monitor the variation,
haplotype subgroup epidemic trends and key mutations of SARS-CoV-2 over time. This is of …